Biopharmaceuticals are complex molecules produced by living cells, with strict control of bioprocessing being required to ensure the production of high-quality therapeutic proteins. Deviations in ...
Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the launch of MAVERICK, an optical in ...
Process analytical technology (PAT), a quality assurance program for the pharmaceutical industry developed by the US Food and Drug Administration, enables pharmaceutical manufacturers to control ...
Developers save money and time while accessing expertise. Accurate and timely analytics are essential to successful development and manufacturing of biopharmaceutical products, whether they are ...
Reaching Bioprocessing 4.0 depends on advanced methods of monitoring and control. For an update on these methods, GEN has organized this roundtable discussion. It presents the insights of four experts ...
Pharmaceutical manufacturing requires defining quality target product profiles and critical quality attributes (CQAs) to ensure desired product quality. Process development identifies critical process ...
The past decade has seen unparalleled growth in the field of cell therapy, which uses cells as therapeutic agents to treat and cure disease. Although the first transplants of blood stem cells date ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results